Terms: = Leukemia AND CHD4, Mi2-BETA, 1108, ENSG00000111642, Mi-2b, DKFZp686E06161, Q14839
31 results:
1. [The Study of Recombinant Interfering Lentiviruses and Overexpressed Adenovirus Vectors Targeting Human
Sun QX; Wu BY; Yao QQ; Huang ZW; Zhu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):274-281. PubMed ID: 38387934
[TBL] [Abstract] [Full Text] [Related]
2. [Efficacy and Safety of Allogeneic Hematopoietic Stem Cell Transplantation with Decitabine-containing Regimen in Myelodysplastic Syndromes and Myelodysplastic Syndromes Transformed Acute Myeloid leukemia].
Wang YX; Sun Y; Xie J; Liu N; Hu JW; Qiao ZQ; Lan SC; Zhao L; Yang Y; Li YH; Zhang B; Hu LD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):522-531. PubMed ID: 37096529
[TBL] [Abstract] [Full Text] [Related]
3. [Clinical study of mesenchymal stem cells from third-party donors in the treatment of refractory late onset hemorrhagic cystitis after allogeneic hematopoietic stem cell transplanation].
Zhao K; Huang F; Chen XY; Chang Y; Xu N; Shi PC; Liu H; Sun J; Xiang P; Liu QF; Fan ZP
Zhonghua Xue Ye Xue Za Zhi; 2022 Jun; 43(6):488-493. PubMed ID: 35968592
[No Abstract] [Full Text] [Related]
4. Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia.
Tirtakusuma R; Szoltysek K; Milne P; Grinev VV; Ptasinska A; Chin PS; Meyer C; Nakjang S; Hehir-Kwa JY; Williamson D; Cauchy P; Keane P; Assi SA; Ashtiani M; Kellaway SG; Imperato MR; Vogiatzi F; Schweighart EK; Lin S; Wunderlich M; Stutterheim J; Komkov A; Zerkalenkova E; Evans P; McNeill H; Elder A; Martinez-Soria N; Fordham SE; Shi Y; Russell LJ; Pal D; Smith A; Kingsbury Z; Becq J; Eckert C; Haas OA; Carey P; Bailey S; Skinner R; Miakova N; Collin M; Bigley V; Haniffa M; Marschalek R; Harrison CJ; Cargo CA; Schewe D; Olshanskaya Y; Thirman MJ; Cockerill PN; Mulloy JC; Blair HJ; Vormoor J; Allan JM; Bonifer C; Heidenreich O; Bomken S
Blood; 2022 Oct; 140(17):1875-1890. PubMed ID: 35839448
[TBL] [Abstract] [Full Text] [Related]
5. Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells.
Yu CH; Yang SQ; Li L; Xin Y; Zhang F; Liu XF; Yi ZC
BMC Pharmacol Toxicol; 2022 Apr; 23(1):20. PubMed ID: 35366954
[TBL] [Abstract] [Full Text] [Related]
6. Combined genomic and proteomic approaches reveal DNA binding sites and interaction partners of TBX2 in the developing lung.
Lüdtke TH; Wojahn I; Kleppa MJ; Schierstaedt J; Christoffels VM; Künzler P; Kispert A
Respir Res; 2021 Mar; 22(1):85. PubMed ID: 33731112
[TBL] [Abstract] [Full Text] [Related]
7. A highly heterogeneous mutational pattern in POEMS syndrome.
Chen J; Gao XM; Zhao H; Cai H; Zhang L; Cao XX; Zhou DB; Li J
Leukemia; 2021 Apr; 35(4):1100-1107. PubMed ID: 33262528
[TBL] [Abstract] [Full Text] [Related]
8. Genome-Wide Association of Kidney Traits in Hispanics/Latinos Using Dense Imputed Whole-Genome Sequencing Data: The Hispanic Community Health Study/Study of Latinos.
Qian H; Kowalski MH; Kramer HJ; Tao R; Lash JP; Stilp AM; Cai J; Li Y; Franceschini N
Circ Genom Precis Med; 2020 Aug; 13(4):e002891. PubMed ID: 32600054
[TBL] [Abstract] [Full Text] [Related]
9. De novo damaging variants associated with congenital heart diseases contribute to the connectome.
Ji W; Ferdman D; Copel J; Scheinost D; Shabanova V; Brueckner M; Khokha MK; Ment LR
Sci Rep; 2020 Apr; 10(1):7046. PubMed ID: 32341405
[TBL] [Abstract] [Full Text] [Related]
10. Directional association test reveals high-quality putative cancer driver biomarkers including noncoding RNAs.
Zhong H; Song M
BMC Med Genomics; 2019 Dec; 12(Suppl 7):129. PubMed ID: 31888644
[TBL] [Abstract] [Full Text] [Related]
11. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
12. MBD3/NuRD loss participates with KDM6A program to promote DOCK5/8 expression and Rac GTPase activation in human acute myeloid leukemia.
Biswas M; Chatterjee SS; Boila LD; Chakraborty S; Banerjee D; Sengupta A
FASEB J; 2019 Apr; 33(4):5268-5286. PubMed ID: 30668141
[TBL] [Abstract] [Full Text] [Related]
13. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial.
Paschka P; Schlenk RF; Weber D; Benner A; Bullinger L; Heuser M; Gaidzik VI; Thol F; Agrawal M; Teleanu V; Lübbert M; Fiedler W; Radsak M; Krauter J; Horst HA; Greil R; Mayer K; Kündgen A; Martens U; Heil G; Salih HR; Hertenstein B; Schwänen C; Wulf G; Lange E; Pfreundschuh M; Ringhoffer M; Girschikofsky M; Heinicke T; Kraemer D; Göhring G; Ganser A; Döhner K; Döhner H
Leukemia; 2018 Jul; 32(7):1621-1630. PubMed ID: 29720733
[TBL] [Abstract] [Full Text] [Related]
14. The chromatin-remodeling factor
Heshmati Y; Türköz G; Harisankar A; Kharazi S; Boström J; Dolatabadi EK; Krstic A; Chang D; Månsson R; Altun M; Qian H; Walfridsson J
Haematologica; 2018 Jul; 103(7):1169-1181. PubMed ID: 29599201
[TBL] [Abstract] [Full Text] [Related]
15. EZH2-, chd4-, and IDH-linked epigenetic perturbation and its association with survival in glioma patients.
Zhang L; Liu Y; Wang M; Wu Z; Li N; Zhang J; Yang C
J Mol Cell Biol; 2017 Dec; 9(6):477-488. PubMed ID: 29272522
[TBL] [Abstract] [Full Text] [Related]
16. Whole exome sequencing identifies novel mutations of epigenetic regulators in chemorefractory pediatric acute myeloid leukemia.
Zhan D; Zhang Y; Xiao P; Zheng X; Ruan M; Zhang J; Chen A; Zou Y; Chen Y; Huang G; Hu S; Wang QF; Zhu X
Leuk Res; 2018 Feb; 65():20-24. PubMed ID: 29253671
[TBL] [Abstract] [Full Text] [Related]
17. In-gap discounts in Medicare Part D and specialty drug use.
Jung J; Xu WY; Cheong C
Am J Manag Care; 2017 Sep; 23(9):553-559. PubMed ID: 29087157
[TBL] [Abstract] [Full Text] [Related]
18. Cancer Risk in 2621 Chinese Patients with Inflammatory Bowel Disease: A Population-based Cohort Study.
So J; Tang W; Leung WK; Li M; Lo FH; Wong MTL; Sze ASF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Lam TY; Lam V; Lee TW; Lo HHH; Tang CM; Wong CL; Wu JCY; Chan FKL; Sung JJY; Harbord M; Ng SC
Inflamm Bowel Dis; 2017 Nov; 23(11):2061-2068. PubMed ID: 28991855
[TBL] [Abstract] [Full Text] [Related]
19. Depletion of the chromatin remodeler chd4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.
Sperlazza J; Rahmani M; Beckta J; Aust M; Hawkins E; Wang SZ; Zu Zhu S; Podder S; Dumur C; Archer K; Grant S; Ginder GD
Blood; 2015 Sep; 126(12):1462-72. PubMed ID: 26265695
[TBL] [Abstract] [Full Text] [Related]
20. Phase II Intergroup Trial of Alisertib in Relapsed and Refractory Peripheral T-Cell Lymphoma and Transformed Mycosis Fungoides: SWOG 1108.
Barr PM; Li H; Spier C; Mahadevan D; LeBlanc M; Ul Haq M; Huber BD; Flowers CR; Wagner-Johnston ND; Horwitz SM; Fisher RI; Cheson BD; Smith SM; Kahl BS; Bartlett NL; Friedberg JW
J Clin Oncol; 2015 Jul; 33(21):2399-404. PubMed ID: 26077240
[TBL] [Abstract] [Full Text] [Related]
[Next]
